A phase I study of prolonged infusion of triapine in combination with fixed dose rate gemcitabine in patients with advanced solid tumors Full Text
Investigational New Drugs, 08/02/2012
Clinical Article
Mortazavi A et al. – The combination was well tolerated and showed evidence of preliminary activity in this heavily pretreated patient population, including prior gemcitabine failure.



